aptaTargets
PrivateLast Round
Grant
Mar 11, 2024
Total Funding Raised
$16.43M
Company Overview
aptaTargets is a biopharmaceutical company that develops aptamer-based therapeutics intended to treat acute conditions driven by inflammation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
aptaTargets Comparables
Compare aptaTargets with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Avilex Pharma | 87% | |
| NoNO Inc. | 84% | |
| FreeOx Biotech | 80% | |
aptaTargets Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 11, 2024 | ||||
| Grant | Feb 19, 2024 | ||||
| Grant | Jan 22, 2024 | ||||
| Series B | Oct 14, 2020 | ||||
| Grant | Jul 1, 2020 | ||||
Series A | May 17, 2017 |
Key People
Founding team and executive leadership
aptaTargets Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Inveready | Series B, Series A |
| Community of Madrid | Grant |
| Criteria Capital Risc | Series A |
| Center for Technological Development and Innovation | Series B |
| Spanish Government (Ministry of Science) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 11, 2024
$2.7M grant awarded by the European Innovation Council.
- Feb 19, 2024
Secured $2M in grant funding from the Community of Madrid.
aptaTargets Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about aptaTargets's valuation, stock price, and market status.